Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.

Fedorova EV, Skochilov RV, Heimer R, Case P, Beletsky L, Grau LE, Kozlov AP, Shaboltas AV.

BMC Public Health. 2013 Mar 1;13:183. doi: 10.1186/1471-2458-13-183.

2.
4.

Nonprescription syringe sales: a missed opportunity for HIV prevention in California.

Pollini RA, Rudolph AE, Case P.

J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):31-40. doi: 10.1331/JAPhA.2015.14148.

5.

Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

Wright-De Agüero L, Weinstein B, Jones TS, Miles J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S102-10.

PMID:
9663632
6.

Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users.

Crawford ND, Amesty S, Rivera AV, Harripersaud K, Turner A, Fuller CM.

Health Educ Behav. 2014 Aug;41(4):397-405. doi: 10.1177/1090198114529131. Epub 2014 Apr 10.

PMID:
24722219
7.

Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.

Lewis BA, Koester SK, Bush TW.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S46-51.

PMID:
12489615
8.

Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.

Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G.

J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):183-92.

PMID:
11404541
9.

Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.

Singer M, Baer HA, Scott G, Horowitz S, Weinstein B.

Public Health Rep. 1998 Jun;113 Suppl 1:81-9.

10.
11.

Over-the-counter but out of reach: a pharmacy-based survey of OTC syringe sales in Tijuana, Mexico.

Pollini RA, Gallardo M, Ruiz S, Case P, Zaller N, Lozada R.

J Health Care Poor Underserved. 2014 May;25(2):637-51. doi: 10.1353/hpu.2014.0090.

PMID:
24858873
12.

Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.

Case P, Beckett GA, Jones TS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S94-101.

PMID:
9663631
13.

Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.

Cooper HL, Bossak BH, Tempalski B, Friedman SR, Des Jarlais DC.

J Urban Health. 2009 Nov;86(6):929-45. doi: 10.1007/s11524-009-9399-7.

14.

Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention.

Zaller ND, Yokell MA, Apeakorang N, Gaggin J, Case P.

J Health Care Poor Underserved. 2012 Aug;23(3):1310-26. doi: 10.1353/hpu.2012.0094.

PMID:
24212176
15.

Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.

Rudolph AE, Crawford ND, Ompad DC, Benjamin EO, Stern RJ, Fuller CM.

J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):140-7. doi: 10.1331/JAPhA.2010.09193.

16.

Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.

Lutnick A, Case P, Kral AH.

J Urban Health. 2012 Apr;89(2):354-64. doi: 10.1007/s11524-011-9651-9.

17.

Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Pollini RA, Lozada R, Gallardo M, Rosen P, Vera A, Macias A, Palinkas LA, Strathdee SA.

AIDS Behav. 2010 Jun;14(3):679-87. doi: 10.1007/s10461-010-9674-3.

18.

Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.

Taussig JA, Weinstein B, Burris S, Jones TS.

AIDS. 2000 Jun;14 Suppl 1:S47-51.

PMID:
10981474
19.

Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.

Ghaddar A, Nassar K, Elsoury G.

Subst Use Misuse. 2017 Apr 21:1-9. doi: 10.1080/10826084.2017.1284235. [Epub ahead of print]

PMID:
28430013
20.

Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Jarlais DD.

J Urban Health. 2009 Nov;86(6):918-28. doi: 10.1007/s11524-009-9400-5. Epub 2009 Nov 18.

Supplemental Content

Support Center